2020 Annual Meeting: 721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities I

Disclosures:

Boglarka Gyurkocza: Actinium - Research Funding; Off Label Use - No.

Kylee Martens: Nothing to Disclose; Off Label Use - No.

Franco Locatelli: Jazz Pharmaceeutical - Speakers Bureau; Novartis - Speakers Bureau; Novartis - Membership on an entity's Board of Directors or advisory committees; Medac - Speakers Bureau; Miltenyi - Speakers Bureau; Bellicum Pharmaceutical - Membership on an entity's Board of Directors or advisory committees; Amgen - Speakers Bureau; Amgen - Membership on an entity's Board of Directors or advisory committees; Off Label Use - Yes.; Paper Off-Labe Use Disclosures -The abstract describes outcomes in patients with non-severe VOD/SOS, who are not included in the indicated population in the product label.

Niketa Shah: Nothing to Disclose; Off Label Use - No.

Alienor Xhaard: Nothing to Disclose; Off Label Use - No.